CMF regimen

View Patient Information

A regimen consisting of cyclophosphamide, methotrexate and fluorouracil, used as a neoadjuvant or adjuvant treatment for breast cancer; also used for the treatment of recurrent and metastatic breast cancer.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	cyclophosphamide-methotrexate-fluorouracil regimen cytoxan-methotrexate-fluorouracil regimen oral cyclophosphamide/methotrexate/fluorouracil
Abbreviation:	CMF CTX/5-FU/MTX
Code name:	cyclophosphamide/fluorouracil/methotrexate

CMF regimen

Search NCI's Drug Dictionary